Real-World Safety of Emicizumab from the European Haemophilia Safety Surveillance (EUHASS) Database
Latest Information Update: 12 Jan 2023
At a glance
- Drugs Emicizumab (Primary) ; Eptacog alfa; Prothrombin complex concentrate
- Indications Haemophilia A
- Focus Adverse reactions
- 13 Dec 2022 Interim Results of Safety of Emicizumab from 2020 and a 2017-2020, presented at the 64th American Society of Hematology Annual Meeting and Exposition
- 11 Jan 2021 New trial record
- 08 Dec 2020 Results of first interim analysis presented at the 62nd Annual Meeting and Exposition of the American Society of Hematology